Skip to main content


Health for Humanity report 2020

Health for Humanity report 2020 

back to Janssen EMEA stories

We’ve just released our Health for Humanity report for 2020 – and set out our new Health for Humanity Goals for 2025. 

Improving the health of people around the world requires a mix of heart, science and ingenuity—something Johnson & Johnson, the largest, most broadly based healthcare company in the world, has known since its founding in 1886. Since 2010, the company has used that custom blend of values to set its Health for Humanity Goals every five years. 

From global access to medications and environmental stewardship to healthy employees, Johnson & Johnson's newly-released 2020 Health for Humanity Report details the progress the company has made over the last five years towards meeting the 17 goals it pledged to achieve by 2020, as well as towards its United Nations (UN) 2030 Sustainable Development Goals (SDGs) Commitment. 

The EMEA region has seen the launch of a website for patients with inflammatory bowel disease, as well as sustainability initiatives in Belgium, where our Beerse campus laboratory has just received LEED Gold certification, the most widely used green building rating system in the world. 

Now the company is looking to build on that progress with its just-announced Health for Humanity 2025 Goals, a set of 21 targets which we believe we can achieve the greatest impact and which reflect our commitment to a healthier world where people and communities can thrive.  

With these goals, Johnson & Johnson is taking on two critical health challenges currently confronting people around the world: pandemics and epidemics, and health equity. The Goals sit under an umbrella of 5 key objectives: 

  • Be prepared to respond quickly to a pandemic through the development of preventive viral vaccines 

  • Develop new treatments to address global health priorities 

  • Strengthen health systems around the world 

  • Support a healthy planet through ambitious climate action 

  • Further advance diversity, equity and inclusion across Johnson & Johnson and its suppliers 

Learn more

back to Janssen EMEA stories